跳至主要内容
临床试验/NCT04927234
NCT04927234已完成不适用

Postoperative Oedema Management of Foot and Ankle Patients with Neuromuscular Electro-stimulation of the Peroneal Nerve Using Geko™

Firstkind Ltd10 个研究点 分布在 3 个国家目标入组 123 人开始时间: 2022年10月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Firstkind Ltd
入组人数
123
试验地点
10
主要终点
Assessment of post-operative oedema formation using the figure-of-eight tape measurement

研究概览

简要总结

The multicentre randomised geko™ Foot and Ankle Trial will prospectively and systematically collect clinical data on patients randomised, on a 1:1 basis, to either standard care or standard care plus geko™ therapy to assess oedema management and patient outcomes during a follow-up period of up to three months post-surgery.

详细描述

The geko™ device has a wide range of clinical applications including the post-operative management of oedema.

Although many short-term acute studies have been completed using the device, little clinical data has been collected on the effect of geko™ use in current standard care pathways for oedema management on patient outcomes during long term follow-up after surgery.

This study is an open label, multi-centre prospective randomised study. The study patient population will be randomised on a 1:1 basis into two groups of 61 patients each. These groups are defined as Group A patients who receive geko™ therapy and SC i.e. the intervention group and Group B patients who receive Standard Care (SC) only i.e. no intervention. The participants will be assessed pre-surgery and up to 90 days post-surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged ≥ 18 years
  • Intact healthy skin at the site of geko™ device application.
  • Patients that have been listed for forefoot and / or hindfoot surgery
  • Patient understands and is willing to participate in the study and can comply with study procedures
  • Patient is willing and able to give written informed consent

排除标准

  • Use of any other neuro-modulation device.
  • Trauma to the lower limbs that would prevent geko™ from stimulating the common peroneal nerve.
  • No response to geko™ therapy i.e. no involuntary rhythmic upward and outward movement of the foot (dorsiflexion) at the maximum tolerable device setting
  • Participation in any other clinical study that may interfere with the outcome of either study

结局指标

主要结局

Assessment of post-operative oedema formation using the figure-of-eight tape measurement

时间窗: From pre-surgery assessment until up to 90 days post-surgery

To assess the effect of geko™ therapy on oedema formation following foot and / or ankle surgery. This will be done using the figure of eight tape measurement method

Assessment of post-operative oedema formation using bioimpedance analysis (US sites only)

时间窗: From pre-surgery assessment until up to 90 days post-surgery

To assess the effect of geko™ therapy on oedema formation following foot and / or ankle surgery using a bioimpedance device to measure resistance to electrical current in both legs and calculating the percentage difference between the operated leg and the contralateral limb.

Assessment of post-operative oedema formation using the pitting oedema scale

时间窗: From pre-surgery assessment until up to 90 days post-surgery

To assess the effect of geko™ therapy on oedema formation following foot and / or ankle surgery using the pitting oedema scale, where following a 2 second firm thumb press, 0 (min) indicates no oedema and 4 (max) is a very deep pit.

次要结局

  • Incidence of surgical wound healing(From surgery until up to 90 days post-surgery)
  • Change in analgesia frequency(From pre-surgery assessment until up to 90 days post-surgery)
  • Incidence of Adverse Events in each group(From pre-surgery assessment until up to 90 days post-surgery)
  • Incidence of device deficiencies(from start of geko treatment (immediately post-surgery) until up to 90 days post-surgery)
  • Change in pain level using a visual analogue scale (VAS) score(From pre-surgery assessment until up to 90 days post-surgery)
  • Change in analgesia dosage(From pre-surgery assessment until up to 90 days post-surgery)
  • Change in patient reported outcomes via Manchester-Oxford Foot & Ankle Questionnaire (MOxFQ)(From pre-surgery assessment until up to 90 days post-surgery)

研究者

发起方
Firstkind Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验